$JD-SW(09618.HK)JD.com reported fourth-quarter results that exceeded expectations.

Revenue growth was fueled by a stronger-than-anticipated performance during the 11.11 (Singles’ Day) shopping festival, indicating that JD continues to hold its ground against rivals like Pinduoduo. Its healthcare subsidiary, JD Health, posted a 26.3% surge in revenue, providing a significant lift to the overall group.

Profitability declined sharply from Q3 ($0.09 vs. $0.52), but still came in slightly ahead of the $0.07 analysts had expected.

Overall, this looks like a moderate relief rally coming when US market open.

Before that, I will keep an eye on the conference call later. It determine the share price direction later.

In short, JD’s financial result were considerably better than the “disaster” scenario the market had priced in. Let’s cross the finger for the best 😁.